265 related articles for article (PubMed ID: 20811074)
1. Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.
Stoop MP; Coulier L; Rosenling T; Shi S; Smolinska AM; Buydens L; Ampt K; Stingl C; Dane A; Muilwijk B; Luitwieler RL; Sillevis Smitt PA; Hintzen RQ; Bischoff R; Wijmenga SS; Hankemeier T; van Gool AJ; Luider TM
Mol Cell Proteomics; 2010 Sep; 9(9):2063-75. PubMed ID: 20811074
[TBL] [Abstract][Full Text] [Related]
2. Quantitative label-free proteomics for discovery of biomarkers in cerebrospinal fluid: assessment of technical and inter-individual variation.
Perrin RJ; Payton JE; Malone JP; Gilmore P; Davis AE; Xiong C; Fagan AM; Townsend RR; Holtzman DM
PLoS One; 2013; 8(5):e64314. PubMed ID: 23700471
[TBL] [Abstract][Full Text] [Related]
3. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data.
Crews B; Wikoff WR; Patti GJ; Woo HK; Kalisiak E; Heideker J; Siuzdak G
Anal Chem; 2009 Oct; 81(20):8538-44. PubMed ID: 19764780
[TBL] [Abstract][Full Text] [Related]
4. The effect of preanalytical factors on stability of the proteome and selected metabolites in cerebrospinal fluid (CSF).
Rosenling T; Slim CL; Christin C; Coulier L; Shi S; Stoop MP; Bosman J; Suits F; Horvatovich PL; Stockhofe-Zurwieden N; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
J Proteome Res; 2009 Dec; 8(12):5511-22. PubMed ID: 19845411
[TBL] [Abstract][Full Text] [Related]
5. The impact of delayed storage on the measured proteome and metabolome of human cerebrospinal fluid.
Rosenling T; Stoop MP; Smolinska A; Muilwijk B; Coulier L; Shi S; Dane A; Christin C; Suits F; Horvatovich PL; Wijmenga SS; Buydens LM; Vreeken R; Hankemeier T; van Gool AJ; Luider TM; Bischoff R
Clin Chem; 2011 Dec; 57(12):1703-11. PubMed ID: 21998343
[TBL] [Abstract][Full Text] [Related]
6. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
7. A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjects.
Gallart-Ayala H; Konz I; Mehl F; Teav T; Oikonomidi A; Peyratout G; van der Velpen V; Popp J; Ivanisevic J
Anal Chim Acta; 2018 Dec; 1037():327-337. PubMed ID: 30292309
[TBL] [Abstract][Full Text] [Related]
8. Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update.
Mandal R; Guo AC; Chaudhary KK; Liu P; Yallou FS; Dong E; Aziat F; Wishart DS
Genome Med; 2012 Apr; 4(4):38. PubMed ID: 22546835
[TBL] [Abstract][Full Text] [Related]
9. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
Núñez Galindo A; Macron C; Cominetti O; Dayon L
Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
[TBL] [Abstract][Full Text] [Related]
10. A novel liquid chromatography/tandem mass spectrometry method for the quantification of glycine as biomarker in brain microdialysis and cerebrospinal fluid samples within 5min.
Voehringer P; Fuertig R; Ferger B
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():92-7. PubMed ID: 24121745
[TBL] [Abstract][Full Text] [Related]
11. Metabolic profiling in multiple sclerosis and other disorders by quantitative analysis of cerebrospinal fluid using nuclear magnetic resonance spectroscopy.
Lutz NW; Cozzone PJ
Curr Pharm Biotechnol; 2011 Jul; 12(7):1016-25. PubMed ID: 21466459
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Synovial Fluid Collection and Processing for NMR Metabolomics and LC-MS/MS Proteomics.
Anderson JR; Phelan MM; Rubio-Martinez LM; Fitzgerald MM; Jones SW; Clegg PD; Peffers MJ
J Proteome Res; 2020 Jul; 19(7):2585-2597. PubMed ID: 32227958
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.
Chiasserini D; van Weering JR; Piersma SR; Pham TV; Malekzadeh A; Teunissen CE; de Wit H; Jiménez CR
J Proteomics; 2014 Jun; 106():191-204. PubMed ID: 24769233
[TBL] [Abstract][Full Text] [Related]
14. Postprandial metabolomics: A pilot mass spectrometry and NMR study of the human plasma metabolome in response to a challenge meal.
Karimpour M; Surowiec I; Wu J; Gouveia-Figueira S; Pinto R; Trygg J; Zivkovic AM; Nording ML
Anal Chim Acta; 2016 Feb; 908():121-31. PubMed ID: 26826694
[TBL] [Abstract][Full Text] [Related]
15. Mass Spectrometry-Based Assay for Targeting Fifty-Two Proteins of Brain Origin in Cerebrospinal Fluid.
Batruch I; Lim B; Soosaipillai A; Brinc D; Fiala C; Diamandis EP
J Proteome Res; 2020 Aug; 19(8):3060-3071. PubMed ID: 32315192
[TBL] [Abstract][Full Text] [Related]
16. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome.
Guo K; Li L
Anal Chem; 2009 May; 81(10):3919-32. PubMed ID: 19309105
[TBL] [Abstract][Full Text] [Related]
17. Label-Free LC-MS/MS Proteomic Analysis of Cerebrospinal Fluid Identifies Protein/Pathway Alterations and Candidate Biomarkers for Amyotrophic Lateral Sclerosis.
Collins MA; An J; Hood BL; Conrads TP; Bowser RP
J Proteome Res; 2015 Nov; 14(11):4486-501. PubMed ID: 26401960
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics in postmortem cerebrospinal fluid diagnostics: a state-of-the-art method to interpret central nervous system-related pathological processes.
Bohnert S; Reinert C; Trella S; Schmitz W; Ondruschka B; Bohnert M
Int J Legal Med; 2021 Jan; 135(1):183-191. PubMed ID: 33180198
[TBL] [Abstract][Full Text] [Related]
19. Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.
Mirian C; Thastrup M; Mathiasen R; Schmiegelow K; Olsen JV; Østergaard O
Fluids Barriers CNS; 2024 Feb; 21(1):14. PubMed ID: 38350915
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
